← Eichor
Condition: Atopic Eczema Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Atopic Eczema

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis
NA · 2 location(s) · Taipei Medical University Shuang Ho Hospital · NCT06636240Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis
Phase 3 · 1 location(s) · Jiangsu vcare pharmaceutical technology co., LTD · NCT07592585CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
Phase N/A · 1 location(s) · CorEvitas · NCT06238765Topical Treatment for Atopic Dermatitis
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06244212A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis
Phase 1 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT07693738Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tral
Phase N/A · 1 location(s) · Hôpitaux Drôme Nord · NCT07568665Registry for Systemic Eczema Treatments
Phase N/A · 1 location(s) · Johns Hopkins University · NCT06136767A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema
NA · 1 location(s) · Dermal Laboratories Ltd · NCT06453512A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers
Phase 1 · 1 location(s) · Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · NCT06082323A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis
Phase 1 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07015762Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis
Phase 2 · 1 location(s) · Keymed Biosciences Co.Ltd · NCT06947980Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxoli
Phase N/A · 1 location(s) · Incyte Corporation · NCT06259669Herbal Ointment in Treating Atopic Dermatitis Topically
Phase 2/Phase 3 · 1 location(s) · En Chu Kong Hospital · NCT06850311Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact
Phase N/A · 2 location(s) · University Hospital Schleswig-Holstein · NCT07444801Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
Phase 2 · 12 location(s) · Alphyn Biologics · NCT06855745Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Phase 1 · 2 location(s) · Seismic Therapeutic AU Pty Ltd · NCT07455578Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic Dermatitis
Phase N/A · 1 location(s) · Zhongda Hospital · NCT07573735Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Phase 1 · 3 location(s) · LAPIX Therapeutics Inc. · NCT06982352A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
Phase 1 · 10 location(s) · Bambusa Therapeutics · NCT07239947A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06732414Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
Phase 4 · 1 location(s) · Northwestern University · NCT05042258Immune Signature of Chronic Hand Eczema Unveiled by Spatial Transcriptomics and Single-Cell Proteomics
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06884163Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis
NA · 1 location(s) · Universitair Ziekenhuis Brussel · NCT07316465Skin Microbial Ecology in Atopic Dermatitis
Phase N/A · 1 location(s) · University of Rochester · NCT04170244A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis
Phase 3 · 2 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07309055Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Phase 1 · 8 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06504160This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · 59 location(s) · Sanofi · NCT07290803A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
Phase 2 · 1 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07211542Lebrikizumab in Moderate-to-severe Atopic Dermatitis
Phase 4 · 4 location(s) · Johann E Gudjonsson MD PhD · NCT06906497Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab
Phase N/A · 1 location(s) · Hôpitaux Drôme Nord · NCT07730788
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.